Has anyone ever seen a story about a guy who got COVID-19, got early treatment with the combo of HCQ, zinc, and Azithromycin, and died anyway?
-
Show this thread
-
Replying to @ScottAdamsSays
I have two issues with this: 1) People want to scientists to support their desire to act on hypotheses prior rigorous study. Sorry... you have to wait. 2) People are conflating, "there is no evidence" with "there will never be evidence". Studies are ongoing.
15 replies 8 retweets 78 likes -
Replying to @LockeBenji
Yes, and coincidentally, the "right" kind of gold standard clinical trial won't be completed until. . . probably November. But the "wrong" kind were completed right away. Smell it yet?
25 replies 77 retweets 834 likes -
Replying to @ScottAdamsSays @LockeBenji
Scott, It’s normal in biomedicine to study sickest pts first. We do it in CA and heart disease. The event rate (death) is common so you don’t need a lot of pts in trials. In early COVID the vast majority get better w pan y aqua. Thus you need tons of pts to show a *sig* diff.
1 reply 0 retweets 2 likes
I made that assumption in a blog post the other day, that it was just easier. But given the growing number of patients and the importance of it, one would expect the early-use trials to at least tell us if ANYONE had yet died with it.
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.